.

Immunogen reported $-62021000 in Net Income for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 924M 3566M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Amgen AMGN:US $ 1317M 159M
Astellas Pharma 4503:JP Y 24812M 33220M
AstraZeneca AZN:LN 29568.96M 177.38M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Bristol Myers Squibb BMY:US $ 1421M 143M
Cerulean Pharma CERU:US $ -8.4M 1.14M
Eli Lilly And LLY:US $ 952.5M 950.4M
Emergent Biosolutions EBS:US $ -56.4M 52.7M
Exelixis EXEL:US $ 70.67M 2.1M
Halozyme Therapeutics HALO:US $ 22.68M 37.42M
Immunogen IMGN:US $ -62.02M 37.88M
Karyopharm Therapeutics KPTI:US $ -49062000 7.66M
Macrogenics MGNX:US $ -41.3M 25.14M
Nektar Therapeutics NKTR:US $ -159.07M 68.68M
Novartis NVS:US $ 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Regeneron Pharmaceuticals REGN:US $ 852.1M 121.4M
Seattle Genetics SGEN:US $ -134.83M 1.67M